---
title: "Enzo Biochem, Inc. (ENZB.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ENZB.US/norm.md"
symbol: "ENZB.US"
name: "Enzo Biochem, Inc."
parent: "https://longbridge.com/en/quote/ENZB.US.md"
datetime: "2026-03-05T17:48:35.810Z"
locales:
  - [en](https://longbridge.com/en/quote/ENZB.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ENZB.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ENZB.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/ENZB.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/ENZB.US/norm.md)


# Enzo Biochem, Inc. (ENZB.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.0532 | -0.0294 | -0.0700 | - | -0.0590 |
| ROE | -21.10% | -10.59% | -23.68% | - | -12.19% |
| Revenue | 6.40M | 7.33M | 6.21M | - | 8.02M |
| Net income | -2.79M | -1.53M | -3.38M | - | -3.02M |

## Balance Sheet (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 63.52M | 67.51M | 75.29M | 85.76M | 93.47M |
| Leverage | 1.46 | 1.45 | 1.58 | 1.53 | 1.35 |
| BVPS | 0.8282 | 0.8896 | 0.9122 | 1.07 | 1.35 |
| Turnover | 0.3500 | 0.3493 | 0.3339 | 0.3073 | 0.4028 |

## Cash Flow Statement (USD)

| Indicator | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -3.22M | -2.03M | -8.99M | - | -2.86M |
| Investing CF | -386000.00 | -70000.00 | 4.55M | - | -143000.00 |
| Financing CF | -42000.00 | -5.32M | -200000.00 | - | -44000.00 |
| Free CF | -1.91M | -6.77M | 2.24M | - | -2.72M |

## Distribution Plan

**Dividend Yield**: 14.31

### Dividend History

| Description | Record Date | Ex-Date | Payment Date |
|-------------|-------------|---------|--------------|
| Cash Dividend: 
0.1USD | 2024-11-15 | 2024-11-15 | 2024-12-02 |